ACTH 11-24

ACTH 11-24, also known as Adrenocorticotropic Hormone fragment 11-24, is a synthetic peptide corresponding to amino acid residues 11 through 24 of the full-length ACTH molecule. As a truncated peptide sequence derived from the endogenous pituitary hormone, it retains specific structural motifs relevant to receptor interaction and signal transduction studies. The biochemical significance of ACTH 11-24 lies in its capacity to serve as a model for dissecting the functional domains of ACTH, allowing researchers to investigate the structure-activity relationships that govern melanocortin receptor engagement and downstream physiological processes. Its defined sequence and manageable size make it a valuable tool for peptide research, enabling precise exploration of molecular mechanisms without the complexity of the full-length hormone.

Receptor binding studies: In the context of receptor pharmacology, ACTH 11-24 is widely employed to probe the binding characteristics and specificity of melanocortin receptors, particularly MC2R and related subtypes. By isolating the central region of the hormone, researchers can elucidate the minimal sequence requirements necessary for receptor activation or antagonism. This peptide fragment facilitates competitive binding assays, aiding in the identification of critical contact residues and informing the rational design of peptide analogs with tailored receptor selectivity or altered signaling profiles.

Peptide structure-activity relationship (SAR) analysis: The use of ACTH 11-24 enables detailed SAR studies, where modifications to individual amino acids within the fragment can reveal the importance of specific side chains or backbone conformations for biological activity. Such investigations are essential for understanding how sequence alterations impact receptor engagement, signal transduction efficacy, and peptide stability. Insights gained from SAR experiments with this fragment can drive the development of optimized analogs for research applications in endocrinology and neurobiology.

Peptide synthesis and analytical method development: As a defined sequence, ACTH 11-24 serves as a reference standard and synthetic intermediate in peptide chemistry laboratories. It is often used to validate solid-phase peptide synthesis protocols, optimize purification strategies, and calibrate analytical techniques such as HPLC and mass spectrometry. Its well-characterized physicochemical properties make it an ideal candidate for method validation, ensuring reproducibility and accuracy in peptide production workflows.

Functional assays in cell signaling research: The fragment is utilized in cell-based assays to assess the activation of intracellular signaling cascades downstream of melanocortin receptors. By comparing the effects of ACTH 11-24 to those of full-length ACTH or other truncated variants, researchers can delineate the contributions of specific domains to cAMP accumulation, steroidogenesis, or other second messenger pathways. These functional assays are instrumental in mapping receptor-ligand interactions and dissecting the molecular underpinnings of hormone action in target cells.

Immunological studies and antibody characterization: ACTH 11-24 is also valuable in immunological research, where it can be used as an antigenic peptide to generate or characterize antibodies specific to the central region of ACTH. Such antibodies are important tools for detecting endogenous hormone fragments in biological samples, studying peptide processing, or validating immunoassays for research applications. By providing a defined epitope, the peptide fragment supports the development of highly specific immunoreagents and the refinement of analytical techniques in peptide immunochemistry.

1. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

2. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

3. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

4. High fat diet and GLP-1 drugs induce pancreatic injury in mice

5. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis